Stockholders' Equity (Details 5) (USD $)
|
0 Months Ended | 1 Months Ended | 12 Months Ended | 0 Months Ended | 3 Months Ended | 1 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 18, 2012
item
investors
|
Sep. 30, 2012
|
Mar. 31, 2012
|
Mar. 31, 2013
|
Mar. 31, 2012
|
Mar. 31, 2011
|
Mar. 05, 2012
|
Sep. 18, 2012
Minimum
|
Nov. 21, 2011
Exercise of September 2009 Warrants, the 2008 Warrants and the 2007 Warrants
|
Mar. 09, 2011
Exercise of the May 2009 Warrants, the 2008 Warrants and the 2007 Warrants
|
Mar. 31, 2011
Exercise of the May 2009 Warrants, the 2008 Warrants and the 2007 Warrants
|
Nov. 21, 2011
Warrants exercised on November 21, 2011
|
Mar. 31, 2012
March 2012
|
Mar. 31, 2013
March 2012
|
Jan. 09, 2012
January 2007
item
|
Nov. 21, 2011
January 2007
item
|
Mar. 09, 2011
January 2007
item
|
Mar. 31, 2012
January 2007
|
Mar. 31, 2011
January 2007
|
Mar. 31, 2010
January 2007
|
Nov. 21, 2011
September 2009
item
|
Mar. 31, 2012
September 2009
|
Mar. 31, 2011
September 2009
|
Mar. 31, 2010
September 2009
|
Nov. 21, 2011
September 2008
item
|
Mar. 09, 2011
September 2008
item
|
Mar. 31, 2012
September 2008
|
Mar. 31, 2011
September 2008
|
Mar. 31, 2013
September 2008
|
Mar. 31, 2010
September 2008
|
Mar. 09, 2011
September 2008
Warrants exercised on March 9, 2011
|
Nov. 21, 2011
September 2008
Warrants exercised on November 22, 2011
|
Mar. 09, 2011
May 2009
item
|
Mar. 31, 2011
May 2009
|
Mar. 31, 2010
May 2009
|
|
Stockholders' Equity | |||||||||||||||||||||||||||||||||||
Common stock sold (in shares) | 22,600,000 | ||||||||||||||||||||||||||||||||||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||||||||||||||||||||||||
Number of shares of common stock under warrants issued | 22,600,000 | 5,800,000 | 1,600,000 | 5,200,000 | 8,500,000 | 2,400,000 | 500,000 | 3,600,000 | |||||||||||||||||||||||||||
Exercise price (in dollars per share) | $ 1.26 | $ 1.41 | $ 1.55 | $ 1.17 | $ 1.17 | $ 1.17 | $ 1.34 | $ 1.60 | $ 1.60 | $ 1.60 | $ 0.95 | ||||||||||||||||||||||||
Number of investors with whom Investor Agreement entered | 1 | ||||||||||||||||||||||||||||||||||
Warrant unit price (in dollars per shares) | $ 1.11 | ||||||||||||||||||||||||||||||||||
Right to purchase maximum additional number of shares of common stock under put option | 19,000,000 | ||||||||||||||||||||||||||||||||||
Number of trading days prior to the exercise of put option | 30 days | ||||||||||||||||||||||||||||||||||
Expenses incurred upon the exercise of warrants | $ 400,000 | $ 1,900,000 | |||||||||||||||||||||||||||||||||
Number of shares of common stock in each unit | 1 | ||||||||||||||||||||||||||||||||||
Number of shares of common stock in each warrant | 1 | ||||||||||||||||||||||||||||||||||
Arithmetic average of the average daily trading volumes on the exercise date (in shares) | 1,750,000 | ||||||||||||||||||||||||||||||||||
Purchase price of additional shares determined pursuant to the Investor Agreement (in dollars per share) | $ 0.94 | ||||||||||||||||||||||||||||||||||
Net proceeds from exercise of warrants | 4,200,000 | 8,400,000 | 11,200,000 | 1,600,000 | 400,000 | ||||||||||||||||||||||||||||||
Number of warrants exercised (in shares) | 7,298,234 | 8,468,324 | 5,780,347 | 3,579,239 | 392,190 | 400,000 | 3,612,717 | ||||||||||||||||||||||||||||
Proceeds from issuance of warrants | 4,250,000 | 11,403,000 | 11,282,000 | 23,100,000 | |||||||||||||||||||||||||||||||
Number of Put Options | 2 | ||||||||||||||||||||||||||||||||||
Number of holders of warrants | 2 | 6 | 4 | 2 | 4 | 1 | 2 | ||||||||||||||||||||||||||||
Outstanding warrants (in shares) | 22,600,000 | 22,550,000 | 22,550,000 | 8,535,574 | 17,003,898 | 5,780,347 | 5,780,347 | 3,910,034 | 7,342,647 | 3,961,471 | 7,686,795 | 3,612,717 | |||||||||||||||||||||||
Fee on exercise of warrants | 300,000 | 1,800,000 | 1,200,000 | 5,400,000 | 2,200,000 | 200,000 | 500,000 | 1,000,000 | |||||||||||||||||||||||||||
Amount charged against earnings for warrant revaluation prior to exercise of warrants | 6,900,000 | ||||||||||||||||||||||||||||||||||
Reduction in amount charged against earnings for warrant revaluation due to induced exercise of warrants | 1,000,000 | ||||||||||||||||||||||||||||||||||
Reduction of warrant liability | $ 9,700,000 |